Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medicinal chemists. The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand […]

WALTHAM, Mass. — Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce Revvity’s rights under its agreements with Cloud Software Group (CSG) related to the Spotfire® software. This ruling follows a preliminary injunction issued in April 2024, which will become permanent, ensuring uninterrupted access […]

DKSH has received Global ISO certifications for environmental practices (ISO 14001) as well as occupational health and safety (ISO 45001) across multiple markets. This achievement reinforces DKSH’s commitment to sustainability and safety in its supply chains, which are continuously improved. DKSH aims to extend these ISO certifications to other key markets in the future. Zurich, […]

New PyMOL interface extends access to Optibrium’s structure-based design method Surflex-Dock CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design today announced the introduction of a new PyMOL Graphical User Interface (GUI) for Surflex-Dock, its industry-leading structure-based design method, which is part of the company’s BioPharmics 3D molecular modelling suite. […]

Tokyo – Hitachi High-Tech Corporation (“Hitachi High-Tech”) and Institute of Science Tokyo (“Science Tokyo”) have been engaged in joint research on the detection of PFAS*1 (“this research”) using Hitachi High-Tech’s proprietary cloud service “Chemicals Informatics” (“CI”). PFAS are resistant to heat, water and oil, and are widely used in all kinds of products, including household and industrial […]

Cambridge, UK Cambridge-based Intellegens today announced a new product suite that represents a step-change in ease-of-implementation and use for machine learning to accelerate R&D. Alchemite™ Suite draws on the power of the Alchemite™ method, a machine learning algorithm that has unique capabilities for working quickly and flexibly with real experimental and process data. The Suite […]

OAKLAND, Calif. — Albert Invent, whose end-to-end R&D platform accelerates chemical innovation in materials science using AI, today announced a $22.5 million Series A funding round led by Coatue, with participation from TCV, Index Ventures, F-Prime, and Homebrew. As part of the announcement, the company also introduced Albert Breakthrough™, the first-ever AI solution built specifically […]

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization. RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has completed the acquisition of Chemaxon. Chemaxon develops leading scientific informatics software products used by the life […]

Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Enamine, the world’s leading chemical and biological contract research organization and producer of novel building blocks for drug design, in the area of targeted protein degradation (TPD). TPD is an exciting research […]

Version 9 of Flare, Cresset’s CADD solution, brings new and enhanced scientific features and methods for all users. These include Homology Modeling to create reliable 3D models for protein targets for which crystallographic information is not available, ensemble Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) on dynamics trajectories for estimating binding free energy, a full integration […]